TNToru Nagasaka

Toru Nagasaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toru Nagasaka has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Free Fatty Acid Receptor 2-Expressing Macrophages in Fibrotic Interstitial Lung Disease—Preliminary Study of Spatial Proximity to Stromal and Epithelial Cells in Lungs

    by Osamu Nishiyama, Mitsugu Fujita, Toru Nagasaka, Masasuke Ohno, Hisako Matsumoto

    Fibrotic interstitial lung disease (f-ILD) progresses at variable rates, and bulk cell densities discard the spatial information behind that variation. Free fatty acid receptor 2 (FFAR2) senses microbial short-chain fatty acids (SCFAs) and restrains macrophage inflammation, but its position in the human fibrotic lung remains unknown. We tested position rather than abundance. In cryobiopsy specimens from 10 patients with fibrotic idiopathic interstitial pneumonia, we combined chromogenic multiplex immunohistochemistry for FFAR2/Iba1 and CD163/Iba1 with deep learning-based image cytometry, mapped single-cell coordinates, and scored each subset’s proximity to stromal cells and the alveolar epithelium with three indices, including the colocalization index (CLI). Proximity of FFAR2-positive macrophages to stromal cells correlated with the 1-year change in forced vital capacity (FVC) (CLI: ρ=0.80, pρ=0.83, pρ=0.87, p<0.01). CD163-positive macrophages showed no such association with FVC, and no index correlated with baseline lung function. In this preliminary cohort, the position of FFAR2-positive macrophages, not their abundance, marks a protective niche and nominates the SCFA-FFAR2 axis as a therapeutic target in f-ILD.

  • Open Access

    Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma: A Pilot Watch-and-Wait Cohort Study

    by Eiji Ito, Masasuke Ohno, Mao Yokota, Shunichiro Kuramitsu, Toru Nagasaka, Toshiaki Inomo, Tadashi Watanabe, Mitsugu Fujita

    Background/Objectives: WHO grade II meningiomas show highly variable growth rates that are difficult to predict using conventional histology. We investigated relationships between immune components within the tumor immune microenvironment (TIME) and explored their association with tumor growth kinetics. Methods: We retrospectively evaluated a small, preselected cohort of 15 patients with WHO grade II meningiomas who underwent initial “watch-and-wait” observation with serial preoperative MRI. Notably, this cohort represents a specific clinical subset—tumors deemed initially observable—and may not be representative of all WHO grade II meningiomas. Densities of Iba1-positive macrophages (TAMs) and B7-H3-positive tumor cells were quantified by digital pathology. The relative growth rate (RGR) was calculated from serial MRI. Results: A strong inverse correlation was observed between TAM density and B7-H3-positive tumor cell density (Spearman’s R = −0.921, p < 0.001). Individual immune components did not show significant linear correlations with RGR; on median-split stratification, high B7-H3-positive tumor cell density was associated with a nominally significant difference in RGR (p = 0.0428, unadjusted). Low TAM density showed a non-significant trend in the same direction. Conclusions: Our findings generate the hypothesis that WHO grade II meningiomas exhibit an inverse relationship between TAMs and B7-H3 and that macrophage-poor/B7-H3-high and macrophage-rich/B7-H3-low patterns may differ in preoperative growth behavior. These observations are derived from a small, preselected cohort of tumors managed with an initial “watch-and-wait” strategy and require validation in broader populations.


  • Open Access

    Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma

    by Eiji Ito, Masasuke Ohno, Mao Yokota, Shunichiro Kuramitsu, Toru Nagasaka, Toshiaki Inomo, Tadashi Watanabe, Mitsugu Fujita

    Background/Objectives: WHO grade II meningiomas exhibit heterogeneous clinical behavior that cannot be predicted by conventional histology. This study examined the relationship between the tumor immune microenvironment (TIME) and tumor growth kinetics in order to establish a biological basis for more precise risk stratification. Methods: A retrospective cohort of 15 patients was evaluated. Serial preoperative magnetic resonance imaging (MRI) scans were used to calculate the relative growth rate (RGR) and minimize the baseline tumor size. The densities of Iba1-positive macrophages (TAMs) and B7-H3-positive tumor cells were quantified using a deep learning-based image analysis system. Results: Linear correlation analysis showed no significant associations between individual immune components and RGR. However, median-based stratification revealed distinct associations. Tumors with low TAM density or high B7-H3-positive tumor cell density exhibited significantly higher RGR (P = 0.0401). Additionally, a significant inverse relationship was identified between TAM and that of B7-H3-positive tumor cell densities (Spearman’s R = -0.911, P < 0.001). Conclusions: We identified a proliferative "immune-cold" phenotype in WHO grade II meningiomas, which is characterized by low TAM density and high B7-H3-positive tumor cell density. This study extends established molecular frameworks by suggesting that high B7-H3-positive tumor cells proactively contribute to rapid tumor growth. These findings highlight the importance of targeting B7-H3-positive tumor cells when treating malignant meningiomas.

  • Open Access

    Spatially-extended Flow Phixer (SpeF-Phixer): A Spatially Extended $\varphi$-Mixing Framework for Gene Regulatory Causal Inference in Spatial Gene Field

    by Toru Nagasaka, Takaaki Tachibana, Yukari Adachi, Hiroki Kagiyama, Ryota Ito, Mitsugu Fujita, Kimihiro Yamashita, Yoshihiro Kakeji

    Background and objective: Spatial transcriptomics provides rich spatial context but lacks sufficient resolution for large-scale causal inference. We developed SpeF-Phixer, a spatially extended phi-mixing framework integrating whole-slide image (WSI)-derived spatial cell distributions with mapped scRNA-seq expression fields to infer directed gene regulatory triplets with spatial coherence. Methods: Using CD103/CD8-immunostained colorectal cancer WSIs and publicly available scRNA-seq datasets, spatial gene fields were constructed around mapped cells and discretized for signed phi-mixing computation. Pairwise dependencies, directional signs, and triplet structures were evaluated through kNN-based neighborhood screening and bootstrap consensus inference. Mediation and convergence were distinguished using generalized additive models (GAMs), with spatial validity assessed by real-null comparisons and database-backed direction checks. Results: Across tissue patches, the pipeline reduced approximately 3.6x10^4 triplet candidates to a reproducible consensus set (approximately 3x10^2 per patch). The downstream edge (Y to Z) showed significant directional bias consistent with curated regulatory databases. Spatial path tracing demonstrated markedly higher coherence for real triplets than for null controls, indicating that inferred chains represent biologically instantiated regulatory flows. Conclusion: SpeF-Phixer extracts spatially coherent, directionally consistent gene regulatory triplets from histological images. This framework bridges single-cell molecular profiles with microenvironmental organization and provides a scalable foundation for constructing spatially informed causal gene networks.

  • Open Access

    Reliability Assessment Framework Based on Feature Separability for Pathological Cell Image Classification under Prior Bias

    by Takaaki Tachibana, Toru Nagasaka, Yukari Adachi, Hiroki Kagiyama, Ryota Ito, Mitsugu Fujita, Kimihiro Yamashita, Yoshihiro Kakeji

    Background and objective: Prior probability shift between training and deployment datasets challenges deep learning-based medical image classification. Standard correction methods reweight posterior probabilities to adjust prior bias, yet their benefit is inconsistent. We developed a reliability framework identifying when prior correction helps or harms performance in pathological cell image analysis. Methods: We analyzed 303 colorectal cancer specimens with CD103/CD8 immunostaining, yielding 185,432 annotated cell images across 16 cell types. ResNet models were trained under varying bias ratios (1.1-20$\times$). Feature separability was quantified using cosine similarity-based likelihood quality scores, reflecting intra- versus inter-class distinctions in learned feature spaces. Multiple linear regression, ANOVA, and generalized additive models (GAMs) evaluated associations among feature separability, prior bias, sample adequacy, and F1 performance. Results: Feature separability dominated performance ($β= 1.650$, $p < 0.001$), showing 412-fold stronger impact than prior bias ($β= 0.004$, $p = 0.018$). GAM analysis showed strong predictive power ($R^2 = 0.876$) with mostly linear trends. A quality threshold of 0.294 effectively identified cases requiring correction (AUC = 0.610). Cell types scoring $>0.5$ were robust without correction, whereas those $<0.3$ consistently required adjustment. Conclusion: Feature extraction quality, not bias magnitude, governs correction benefit. The proposed framework provides quantitative guidance for selective correction, enabling efficient deployment and reliable diagnostic AI.

  • Open Access

    Tumor-Infiltrating B Cells and Tissue-Resident Memory T Cells as Prognostic Indicators in Brain Metastases Derived from Gastrointestinal Cancers

    by Masasuke Ohno, Shunichiro Kuramitsu, Kimihiro Yamashita, Toru Nagasaka, Shoichi Haimoto, Mitsugu Fujita

    Background/Objectives: Tumor-infiltrating B cells (TIBs) and tissue-resident memory T cells (TRMs) play significant roles in antitumor immunity. However, their prognostic relevance in brain metastases (BMs) derived from gastrointestinal (GI) cancers remains unclear. This study aimed to investigate the prognostic significance of TIBs and TRMs in GI cancer-derived BMs (GIBMs). Methods: Retrospective histopathological analyses were performed on surgically resected GIBM tissues from 13 patients. The densities of tumor-infiltrating lymphocytes (TIL) subsets (TIBs, CD4+ T cells, CD8+CD103+ TRMs, and CD8+CD103- non-TRMs) were quantified and correlated with clinical parameters and overall survival (OS) including the Graded Prognostic Assessment (GPA). Results: TIBs and CD4+ T cells were predominantly accumulated in the tumor stroma, particularly around blood vessels, where they formed lymphocyte clusters without characteristics of tertiary lymphoid structures (TLSs). In contrast, TRMs more deeply infiltrated into the tumor epithelium than their counterpart non-TRMs. Positive correlations were found between TIB density and both the prognostic prediction of GPA and overall survival (OS) after BM diagnosis or surgery. Furthermore, increased densities of TIBs and TRMs were associated with enhanced survival after BM diagnosis. Conclusions: TIB and TRM densities in BM tissues could serve as reliable prognostic indicators for survival in patients with GIBMs. This study provides crucial insights for the development of novel immunotherapeutic strategies against this lethal disease.


  • Purely Endoscopic Evacuation of Intracranial Hematomas

    by Hisayuki Murai, Takuji Yamamoto, Toru Nagasaka

    Cerebral hemorrhage is a frequent disease and one of the main causes of disabilities. Even in the case of cerebral hemorrhage, if there were a treatment that would improve the functional prognosis, the benefits would be immeasurable. Although there are limited reports with a high level of evidence in past studies, it has been found that surgery can be effective if a large amount of hematoma can be removed in a minimally invasive manner. Also, it has become clear that the control of bleeding becomes a problem when surgery is performed within 2 days after the onset of stroke and that the therapeutic time window might be longer. In Japan, since the introduction of the transparent sheath by Nishihara et al., endoscopic hematoma removal has been widely performed and has become the standard surgical procedure. The three basic equipment needed for this surgery are a rigid scope, a suction coagulator, and a transparent sheath. The key point of the surgery is to search for hematomas and bleeding points through a transparent sheath and coagulate the bleeding vessels. In this chapter, we will introduce surgical techniques using these devices, but it is important to carefully decide on surgical options by considering your own technique, the condition of each patient, and the devices available in the area.

  • What does the CT angiography “spot sign” of intracerebral hemorrhage mean in modern neurosurgical settings with minimally invasive endoscopic techniques?

    by Toru Nagasaka, Suguru Inao, Toshihiko Wakabayashi

    Hematoma expansion is correlated with morbidity and mortality for patients with intracerebral hemorrhage (ICH). Recent studies demonstrated that contrast extravasation on contrast-enhanced CT and small-enhancing foci, so-called spot signs, on CT angiography are associated with subsequent hematoma enlargement. Such radiological markers of ICH may have significant implications not only as a surrogate marker for hematoma expansion in medical hemostatic therapy but also as indication for surgery. In this article, a brief description of contrast extravasation and “spot sign” will be provided first. The findings of some of the important trials that shaped the current landscape of therapeutic interventions for ICH will then be reviewed. Many neurosurgeons have faced a significant dilemma since the Surgical Trial in Intracerebral Haemorrhage (STICH) trial was published. Under adverse circumstances, many neurosurgeons assume that minimally invasive surgical interventions are still likely to benefit some patients and will be more effective. Among future candidate strategies for ICH, the most promising is neuroendoscopic surgery with direct hemostatic devices, which attains direct local hemostasis at the sites of vascular rupture. It is plausible that ultra-early direct hemostatic surgery given in the emergency setting might reduce hematoma volume and rebleeding and improve outcome. Finally, a description of future avenues of minimally invasive surgery for ICH treatment and suggestions for the design of further studies using reliable predictor of hematoma expansion spot sign will be provided. Neuroendoscopic interventions are minimally invasive and are likely of benefit in hemostasis and hematoma removal. On the basis of these observations, the spot sign of ICH has sub-emergency surgical implications.


  • A novel monoshaft bipolar cautery for use in endoscopic intracranial surgery. A short technical note

    by Toru Nagasaka, Masanori Tsugeno, Hiroshi Ikeda, Takeshi Okamoto, Suguru Inao, Toshihiko Wakabayashi